Clinical and laboratory findings in patients with dengue associated with hepatopathy
INTRODUCTION: Hepatic disorders caused by dengue infection may progress to severe manifestations, including mortality and morbidity. Cytokines are involved in it, such as the migration inhibitory factor of macrophages (MIF), tumor necrosis factor (TNF), natural killer cells (NK), B lymphocytes, and macrophages. METHODS: This study was carried out from January to April 2007 at a public hospital from the Federal University of Mato Grosso do Sul, Campo Grande, Brazil. Sixty-eight patients were studied concerning hepatic alterations, with 56 reported having classic dengue, 6 with hemorrhagic dengue grade I, and 6 with hemorrhagic dengue grade II. RESULTS: Among the 56 with classic dengue, 83.3% had aspartate aminotransferase (AST) alterations, and 69.6% had altered alanine aminotransferase (ALT). For those with hemorrhagic dengue grade I, 100% had AST alterations, and 83.3% had altered ALT. All the patients with hemorrhagic dengue grade II had AST and ALT alterations. AST variations reached 22.0 and 907.0, with an average value of 164.6. For ALT, we found variations between 25.0 and 867.0, with an average value of 166.07. There had been statistical significance between dengue clinical shapes and hepatic function markers. CONCLUSIONS: We conclude that the infection was predominant in adults, females, and in those with low income and education. The liver enzymes were of larger amount in hemorrhagic dengue, but there was weak statistical evidence of the clinical manifestations and transaminases. Major signs and clinical symptoms were fever, headache, myalgia, arthralgia, weakness, severe pain behind the eyes, and rashes.
Main Authors: | , , , , , , , |
---|---|
Format: | Digital revista |
Language: | English |
Published: |
Sociedade Brasileira de Medicina Tropical - SBMT
2011
|
Online Access: | http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0037-86822011000600005 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
id |
oai:scielo:S0037-86822011000600005 |
---|---|
record_format |
ojs |
spelling |
oai:scielo:S0037-868220110006000052012-01-06Clinical and laboratory findings in patients with dengue associated with hepatopathyNascimento,Delso doCastro,Ana Rita Coimbra Motta deFroes,Íris BuckerBigaton,GláuciaOliveira,Éveny Cristine Luna deDal Fabbro,Márcia Ferrario JanineCunha,Rivaldo Venâncio daCosta,Izaias Pereira da Dengue Hemorrhagic dengue Hepatitis INTRODUCTION: Hepatic disorders caused by dengue infection may progress to severe manifestations, including mortality and morbidity. Cytokines are involved in it, such as the migration inhibitory factor of macrophages (MIF), tumor necrosis factor (TNF), natural killer cells (NK), B lymphocytes, and macrophages. METHODS: This study was carried out from January to April 2007 at a public hospital from the Federal University of Mato Grosso do Sul, Campo Grande, Brazil. Sixty-eight patients were studied concerning hepatic alterations, with 56 reported having classic dengue, 6 with hemorrhagic dengue grade I, and 6 with hemorrhagic dengue grade II. RESULTS: Among the 56 with classic dengue, 83.3% had aspartate aminotransferase (AST) alterations, and 69.6% had altered alanine aminotransferase (ALT). For those with hemorrhagic dengue grade I, 100% had AST alterations, and 83.3% had altered ALT. All the patients with hemorrhagic dengue grade II had AST and ALT alterations. AST variations reached 22.0 and 907.0, with an average value of 164.6. For ALT, we found variations between 25.0 and 867.0, with an average value of 166.07. There had been statistical significance between dengue clinical shapes and hepatic function markers. CONCLUSIONS: We conclude that the infection was predominant in adults, females, and in those with low income and education. The liver enzymes were of larger amount in hemorrhagic dengue, but there was weak statistical evidence of the clinical manifestations and transaminases. Major signs and clinical symptoms were fever, headache, myalgia, arthralgia, weakness, severe pain behind the eyes, and rashes.info:eu-repo/semantics/openAccessSociedade Brasileira de Medicina Tropical - SBMTRevista da Sociedade Brasileira de Medicina Tropical v.44 n.6 20112011-12-01info:eu-repo/semantics/articletext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S0037-86822011000600005en10.1590/S0037-86822011005000061 |
institution |
SCIELO |
collection |
OJS |
country |
Brasil |
countrycode |
BR |
component |
Revista |
access |
En linea |
databasecode |
rev-scielo-br |
tag |
revista |
region |
America del Sur |
libraryname |
SciELO |
language |
English |
format |
Digital |
author |
Nascimento,Delso do Castro,Ana Rita Coimbra Motta de Froes,Íris Bucker Bigaton,Gláucia Oliveira,Éveny Cristine Luna de Dal Fabbro,Márcia Ferrario Janine Cunha,Rivaldo Venâncio da Costa,Izaias Pereira da |
spellingShingle |
Nascimento,Delso do Castro,Ana Rita Coimbra Motta de Froes,Íris Bucker Bigaton,Gláucia Oliveira,Éveny Cristine Luna de Dal Fabbro,Márcia Ferrario Janine Cunha,Rivaldo Venâncio da Costa,Izaias Pereira da Clinical and laboratory findings in patients with dengue associated with hepatopathy |
author_facet |
Nascimento,Delso do Castro,Ana Rita Coimbra Motta de Froes,Íris Bucker Bigaton,Gláucia Oliveira,Éveny Cristine Luna de Dal Fabbro,Márcia Ferrario Janine Cunha,Rivaldo Venâncio da Costa,Izaias Pereira da |
author_sort |
Nascimento,Delso do |
title |
Clinical and laboratory findings in patients with dengue associated with hepatopathy |
title_short |
Clinical and laboratory findings in patients with dengue associated with hepatopathy |
title_full |
Clinical and laboratory findings in patients with dengue associated with hepatopathy |
title_fullStr |
Clinical and laboratory findings in patients with dengue associated with hepatopathy |
title_full_unstemmed |
Clinical and laboratory findings in patients with dengue associated with hepatopathy |
title_sort |
clinical and laboratory findings in patients with dengue associated with hepatopathy |
description |
INTRODUCTION: Hepatic disorders caused by dengue infection may progress to severe manifestations, including mortality and morbidity. Cytokines are involved in it, such as the migration inhibitory factor of macrophages (MIF), tumor necrosis factor (TNF), natural killer cells (NK), B lymphocytes, and macrophages. METHODS: This study was carried out from January to April 2007 at a public hospital from the Federal University of Mato Grosso do Sul, Campo Grande, Brazil. Sixty-eight patients were studied concerning hepatic alterations, with 56 reported having classic dengue, 6 with hemorrhagic dengue grade I, and 6 with hemorrhagic dengue grade II. RESULTS: Among the 56 with classic dengue, 83.3% had aspartate aminotransferase (AST) alterations, and 69.6% had altered alanine aminotransferase (ALT). For those with hemorrhagic dengue grade I, 100% had AST alterations, and 83.3% had altered ALT. All the patients with hemorrhagic dengue grade II had AST and ALT alterations. AST variations reached 22.0 and 907.0, with an average value of 164.6. For ALT, we found variations between 25.0 and 867.0, with an average value of 166.07. There had been statistical significance between dengue clinical shapes and hepatic function markers. CONCLUSIONS: We conclude that the infection was predominant in adults, females, and in those with low income and education. The liver enzymes were of larger amount in hemorrhagic dengue, but there was weak statistical evidence of the clinical manifestations and transaminases. Major signs and clinical symptoms were fever, headache, myalgia, arthralgia, weakness, severe pain behind the eyes, and rashes. |
publisher |
Sociedade Brasileira de Medicina Tropical - SBMT |
publishDate |
2011 |
url |
http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0037-86822011000600005 |
work_keys_str_mv |
AT nascimentodelsodo clinicalandlaboratoryfindingsinpatientswithdengueassociatedwithhepatopathy AT castroanaritacoimbramottade clinicalandlaboratoryfindingsinpatientswithdengueassociatedwithhepatopathy AT froesirisbucker clinicalandlaboratoryfindingsinpatientswithdengueassociatedwithhepatopathy AT bigatonglaucia clinicalandlaboratoryfindingsinpatientswithdengueassociatedwithhepatopathy AT oliveiraevenycristinelunade clinicalandlaboratoryfindingsinpatientswithdengueassociatedwithhepatopathy AT dalfabbromarciaferrariojanine clinicalandlaboratoryfindingsinpatientswithdengueassociatedwithhepatopathy AT cunharivaldovenancioda clinicalandlaboratoryfindingsinpatientswithdengueassociatedwithhepatopathy AT costaizaiaspereirada clinicalandlaboratoryfindingsinpatientswithdengueassociatedwithhepatopathy |
_version_ |
1756380464948445184 |